The Rheumatologist
COVID-19 NewsACR Convergence
You are here: Home / Articles / Pediatric Uveitis in the Biologic Age: Risk Factors, Treatment & Outcomes

Pediatric Uveitis in the Biologic Age: Risk Factors, Treatment & Outcomes

• By

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Simonini G, Bracaglia C, Cattalini M, et al. Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis. J Rheumatol. 2017 Jun;44(6):822–826.
  2. Angeles-Han ST, Rabinovich CE. Uveitis in children. Curr Opin Rheumatol. 2016 Sep;28(5):544–549.

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »